|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Verdezyne Raises $10.6M to Advance Sustainable Chemicals Technology
|
Bruce V. Bigelow |
05/11/12 |
San Diego
|
|
Symform Receives $11,000,000 Series B Round
|
VentureDeal |
04/25/12 |
Seattle
|
|
Some Tongue-in-Cheek Fantasy Baseball (and Biotech) Picks
|
Luke Timmerman |
03/26/12 |
National
|
|
OVP, Looking for a Home Run, Hits Bunt Single With Complete Genomics
|
Luke Timmerman |
03/21/12 |
Seattle
|
|
DataSphere Obtains $8,000,000 Series D Financing Round
|
VentureDeal |
03/15/12 |
Seattle
|
|
Allozyne “Redistributes” Workforce After Scrapping Poniard Merger Plan
|
Luke Timmerman |
01/03/12 |
Seattle
|
|
Allozyne Raises More VC Cash, Looks to FDA Meeting After Poniard Deal Fizzles
|
Luke Timmerman |
12/23/11 |
Seattle
|
|
Allozyne Receives New Round
|
VentureDeal |
12/23/11 |
Seattle
|
|
Allozyne, Poniard Scrap Plan to Merge Amid Investor Apathy
|
Luke Timmerman |
12/22/11 |
Seattle
|
|
Fate Therapeutics Names Biotech Vet Bill Rastetter as Chairman, Interim CEO
|
Luke Timmerman |
12/14/11 |
San Diego
|
|
Groove Biopharma Snags $6M to Push the Frontiers With MicroRNA Drugs
|
Luke Timmerman |
12/12/11 |
Seattle
|
|
Groove Biopharma Receives $8,000,000 Series B Financing
|
VentureDeal |
12/12/11 |
Seattle
|
|
Tigo Energy Secures $18,000,000 New Funding
|
VentureDeal |
12/12/11 |
San Francisco
|
|
Verdezyne Claims Milestone in Renewable Replacement of Petrochemical
|
Bruce V. Bigelow |
11/30/11 |
San Diego
|
|
Best Buy Picks Up MindShift, Termeer Funds NanoString, Basho Adds $5M More, & More Boston-Area Deals News
|
Erin Kutz |
11/09/11 |
Boston
|
|
NanoString Grabs $20M From GE, Former Genzyme CEO to Pursue Molecular Diagnostics
|
Luke Timmerman |
11/07/11 |
Seattle
|
|
NanoString Technologies Obtains $20,000,000 Series D Funding
|
VentureDeal |
11/07/11 |
Seattle
|
|
Illumina Leads $8M Investment in GenoLogics to Help Manage DNA Data Overload
|
Luke Timmerman |
10/20/11 |
Seattle
|
|
Northwest Deals: Hootsuite, Symform, Avalara, X2Impact, Osprit
|
Curt Woodward |
09/16/11 |
Seattle
|
|
Lucid Commerce Gets $8M More
|
Gregory T. Huang |
07/29/11 |
Seattle
|
|
Lucid Commerce Lands $8,000,000 Series C Funding
|
VentureDeal |
07/29/11 |
Seattle
|
|
Fate Therapeutics Trims Chemistry Staff, Bets on Biotech Drugs
|
Luke Timmerman |
07/07/11 |
National
|
|
ExtraHop, Profibrix, Avalara Lead Way Toward $70M in Equity Deals for WA Companies in May
|
Curt Woodward |
06/21/11 |
Seattle
|
|
Oncofactor Garners $2,100,000 Series A Financing Round
|
VentureDeal |
05/25/11 |
Seattle
|
|
GainSpan Gains $10.2M
|
Wade Roush |
05/23/11 |
San Francisco
|
|
Adapx, a Digital-Pen Company With Serious Military Chops, Adds $5M to Modernize Note-Taking
|
Curt Woodward |
05/20/11 |
Seattle
|
|
Adapx Garners $5,000,000 New Funding Round
|
VentureDeal |
05/20/11 |
Seattle
|
|
Takeda Bets on Fate Therapeutics
|
Luke Timmerman |
05/10/11 |
San Diego
|
|
Verdezyne Closes Funding Round
|
Bruce V. Bigelow |
05/09/11 |
San Diego
|
|
EnerG2 Moves Into ‘Execute Mode’ to Enhance Batteries, Natural Gas Cars
|
Luke Timmerman |
04/06/11 |
Seattle
|
|
Page 1 of
8 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.